LT2512453T - Granulės farmaciniams preparatams, jų gamybos būdai ir prietaisai - Google Patents

Granulės farmaciniams preparatams, jų gamybos būdai ir prietaisai

Info

Publication number
LT2512453T
LT2512453T LTEP10793226.1T LT10793226T LT2512453T LT 2512453 T LT2512453 T LT 2512453T LT 10793226 T LT10793226 T LT 10793226T LT 2512453 T LT2512453 T LT 2512453T
Authority
LT
Lithuania
Prior art keywords
granules
production
methods
pharmaceutical preparations
preparations
Prior art date
Application number
LTEP10793226.1T
Other languages
English (en)
Inventor
Carsten Hoeg-Moller
Crilles Casper Larsen
Jorgen Wittendorff
Brigitte Nissen
Kenneth Manby Pedersen
Tue Hansen
Helle Poulsen
Original Assignee
Ferring B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42110308&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2512453(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring B.V. filed Critical Ferring B.V.
Publication of LT2512453T publication Critical patent/LT2512453T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/609—Amides, e.g. salicylamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LTEP10793226.1T 2009-12-18 2010-12-15 Granulės farmaciniams preparatams, jų gamybos būdai ir prietaisai LT2512453T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09179877A EP2340812A1 (en) 2009-12-18 2009-12-18 Granules for pharmaceutical preparations, methods and apparatus for their production
PCT/EP2010/069733 WO2011073245A2 (en) 2009-12-18 2010-12-15 Granules for pharmaceutical preparations, methods and apparatus for their production

Publications (1)

Publication Number Publication Date
LT2512453T true LT2512453T (lt) 2016-12-27

Family

ID=42110308

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP10793226.1T LT2512453T (lt) 2009-12-18 2010-12-15 Granulės farmaciniams preparatams, jų gamybos būdai ir prietaisai

Country Status (28)

Country Link
US (2) US8765185B2 (lt)
EP (2) EP2340812A1 (lt)
JP (1) JP5593396B2 (lt)
KR (1) KR101882880B1 (lt)
CN (2) CN102791257B (lt)
AR (1) AR079536A1 (lt)
AU (1) AU2010332884B2 (lt)
BR (1) BR112012014935B1 (lt)
CA (1) CA2784235C (lt)
DK (1) DK2512453T4 (lt)
ES (1) ES2612870T5 (lt)
FI (1) FI2512453T4 (lt)
HR (1) HRP20161639T4 (lt)
HU (1) HUE031228T2 (lt)
IL (1) IL220319A (lt)
JO (1) JO3762B1 (lt)
LT (1) LT2512453T (lt)
MX (2) MX2012006851A (lt)
NL (1) NL1038373C2 (lt)
NZ (1) NZ600582A (lt)
PL (1) PL2512453T5 (lt)
PT (1) PT2512453T (lt)
RS (1) RS55438B2 (lt)
RU (1) RU2584349C2 (lt)
SI (1) SI2512453T2 (lt)
TW (1) TWI511723B (lt)
WO (1) WO2011073245A2 (lt)
ZA (1) ZA201204441B (lt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007523664A (ja) 2003-04-23 2007-08-23 フェリング ベスローテン フェンノートシャップ 医薬組成物用サシェ
SMT202400116T1 (it) 2008-10-02 2024-05-14 Salix Pharmaceuticals Ltd Trattamento dell’encefalopatia epatica utilizzando rifaximina
EP2340812A1 (en) 2009-12-18 2011-07-06 Ferring International Center S.A. Granules for pharmaceutical preparations, methods and apparatus for their production
US20140141075A1 (en) 2012-11-21 2014-05-22 Warner Chilcott Company, Llc 5-aminosalicylic acid capsule formulation
DE202017102645U1 (de) * 2017-05-03 2018-08-06 Romaco Kilian Gmbh Ablaufvorrichtung für Presslinge einer Rundläufer-Tablettenpresse sowie Rundläufer-Tablettenpresse mit Ablaufvorrichtung
RU2667637C1 (ru) * 2017-06-26 2018-09-21 Гермес Арцнаймиттель ГмбХ Фармацевтическая композиция для перорального применения, содержащая n-ацетилцистеин с маскированным вкусом
ES2938608T3 (es) 2017-09-20 2023-04-13 Tillotts Pharma Ag Método para preparar una forma farmacéutica sólida que comprende anticuerpos mediante granulación en húmedo, extrusión y esferonización
EP3459529A1 (en) 2017-09-20 2019-03-27 Tillotts Pharma Ag Preparation of sustained release solid dosage forms comprising antibodies by spray drying
ES2938609T3 (es) 2017-09-20 2023-04-13 Tillotts Pharma Ag Preparación de formas farmacéuticas sólidas que comprenden anticuerpos mediante estratificación de solución/suspensión
KR102161235B1 (ko) * 2020-07-22 2020-09-29 주식회사 피티케이 이송 일체형 과립 제조 장치 및 방법
US20240032570A1 (en) * 2020-08-18 2024-02-01 Uha Mikakuto Co., Ltd. Oral fast-disintegrating solid food and method for manufacturing same
CN114472139A (zh) * 2022-01-04 2022-05-13 安徽宏信药业发展有限公司 一种中药药丸干燥筛选装置
CN115445902B (zh) * 2022-09-21 2023-06-06 重庆科技学院 一种条形颗粒物三维尺寸分选方法及装置
WO2024200722A1 (en) 2023-03-28 2024-10-03 Tillotts Pharma Ag Solid oral dosage form comprising antibodies for sustained release in the lower gastrointestinal tract
CN116942532B (zh) * 2023-09-20 2023-12-12 北京爱力佳医药科技有限公司 一种粉状药物制备装置

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002671A1 (en) 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
US4720473A (en) * 1986-03-10 1988-01-19 Cri International, Inc. Production of improved catalyst-type particles using length and density grading
DE3786544T2 (de) * 1986-03-10 1994-02-03 Cri Int Inc Verfahren zur Sortierung und Isolierung von Katalysator-Formteilchen nach ihrer Länge.
JPH0827133B2 (ja) 1993-07-13 1996-03-21 不二パウダル株式会社 湿潤粉粒体の処理装置
US6004581A (en) * 1995-12-21 1999-12-21 Farmaceutisk Laboratorium Ferring A/S Modified release oral pharmaceutical composition and method for the treatment of bowel diseases
KR100542544B1 (ko) 1995-12-21 2006-05-10 파마슈티스크 라보라토리움 페링 에이/에스 5-아미노살리실산을함유하는방출제어형경구용약제학적조성물및장질환을치료하는방법
AUPO637197A0 (en) 1997-04-23 1997-05-15 F.H. Faulding & Co. Limited Taste-masked pharmaceutical compositions
DE19724181A1 (de) * 1997-06-09 1998-12-10 Bayer Ag Multiple-unit-retard-Zubereitungen und Verfahren zu ihrer Herstellung
JP2000128774A (ja) 1998-10-26 2000-05-09 Tanabe Seiyaku Co Ltd 薬物を含有する球形微粒子の製法
US6146685A (en) 1998-11-05 2000-11-14 Delsys Pharmaceutical Corporation Method of deposition a dry powder and dispensing device
AU764469B2 (en) * 1999-01-29 2003-08-21 Disphar International B.V. Pharmaceutical compositions
US6735487B1 (en) 1999-07-01 2004-05-11 Ods Properties, Inc. Interactive wagering system with promotions
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
US8282955B2 (en) 2001-10-15 2012-10-09 Ferring B.V. Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
PT1441700E (pt) 2001-10-15 2007-10-29 Ferring Bv Método para a preparação de uma composição compreendendo ácido 5-aminosalicílico para uso em tratamento de colites ulcerosas ou da doença de crohn
US7445796B2 (en) 2002-08-19 2008-11-04 L. Perrigo Company Pharmaceutically active particles of a monomodal particle size distribution and method
JP2007523664A (ja) 2003-04-23 2007-08-23 フェリング ベスローテン フェンノートシャップ 医薬組成物用サシェ
EP1470819A1 (en) * 2003-04-23 2004-10-27 Ferring B.V. High drug load mesalazine sachet
EP1547601A1 (en) * 2003-12-23 2005-06-29 Ferring B.V. Coating method
US7207505B2 (en) 2004-06-04 2007-04-24 Bender Martin P Method for producing small granules
DE102004028977A1 (de) * 2004-06-16 2006-01-05 Add Advanced Drug Delivery Technologies Ltd. Neutralpellets
JP2009521402A (ja) 2005-11-17 2009-06-04 テバ ファーマシューティカル インダストリーズ リミティド プロパルギル化アミノインダンの分離のための方法
EP2340812A1 (en) 2009-12-18 2011-07-06 Ferring International Center S.A. Granules for pharmaceutical preparations, methods and apparatus for their production

Also Published As

Publication number Publication date
WO2011073245A2 (en) 2011-06-23
DK2512453T3 (en) 2017-01-09
TWI511723B (zh) 2015-12-11
PT2512453T (pt) 2016-12-16
JP2013514312A (ja) 2013-04-25
ES2612870T5 (en) 2025-05-09
MX2012006851A (es) 2012-08-31
NZ600582A (en) 2014-09-26
KR101882880B1 (ko) 2018-07-27
ZA201204441B (en) 2013-02-27
AR079536A1 (es) 2012-02-01
US20140328934A1 (en) 2014-11-06
AU2010332884A1 (en) 2012-07-05
TW201125556A (en) 2011-08-01
ES2612870T3 (es) 2017-05-19
EP2512453B1 (en) 2016-11-09
WO2011073245A3 (en) 2011-08-11
PL2512453T3 (pl) 2017-03-31
HUE031228T2 (en) 2017-07-28
SI2512453T1 (sl) 2017-02-28
PL2512453T5 (pl) 2025-07-07
CA2784235A1 (en) 2011-06-23
FI2512453T4 (fi) 2025-05-23
NL1038373C2 (en) 2011-06-21
CN105769772A (zh) 2016-07-20
CA2784235C (en) 2019-01-15
BR112012014935A2 (pt) 2016-03-08
SI2512453T2 (sl) 2025-06-30
KR20120102775A (ko) 2012-09-18
RS55438B1 (sr) 2017-04-28
RU2584349C2 (ru) 2016-05-20
MX351365B (es) 2017-10-12
DK2512453T4 (da) 2025-06-02
JP5593396B2 (ja) 2014-09-24
IL220319A0 (en) 2012-08-30
CN102791257A (zh) 2012-11-21
EP2340812A1 (en) 2011-07-06
HRP20161639T1 (hr) 2017-02-10
EP2512453A2 (en) 2012-10-24
AU2010332884B2 (en) 2015-12-10
US8765185B2 (en) 2014-07-01
IL220319A (en) 2016-03-31
HRP20161639T4 (hr) 2025-06-20
CN102791257B (zh) 2017-03-01
RS55438B2 (sr) 2025-06-30
RU2012124834A (ru) 2014-01-27
US9114083B2 (en) 2015-08-25
BR112012014935B1 (pt) 2021-12-21
FI2512453T9 (fi) 2025-06-13
JO3762B1 (ar) 2021-01-31
EP2512453B2 (en) 2025-03-12
US20130022681A1 (en) 2013-01-24

Similar Documents

Publication Publication Date Title
ZA201204441B (en) Granules for pharmaceutical preparations,methods and apparatus for their production
AP3724A (en) Security elements, and methods and apparatus for their manufacture
EP2481739A4 (en) DIHYDROPTERIDINONE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL USE
IL245050A0 (en) Optimum fc variants, pharmaceutical preparations and drugs containing them, and a method for their preparation
IL225597A0 (en) Pharmaceutical preparation, methods of treatment and its uses
PL2672966T3 (pl) Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania
ZA201300100B (en) Indolizine derivatives,process for the preparation thereof and therapeutic use thereof
ZA201102760B (en) Process for preparing chlorins and their pharmaceutical uses
EP2585606A4 (en) SUGAR MIXTURES, METHODS OF PRODUCTION AND USE THEREOF
AP3222A (en) Germination-stimulant carbamate derivatives and process for preparation thereof
ZA201200770B (en) Chromone derivatives, a process for their preparation and their therapeutic applications
EP2763998A4 (en) TRI-HETEROCYCLIC DERIVATIVES, MANUFACTURING METHOD AND USES THEREOF
HUP1000366D0 (en) Novel proteins, their production process and use tereof
EP2578725A4 (en) COATED ELEMENT AND METHOD FOR PRODUCING THE SAME
ZA201309559B (en) Comptothecin derivative, method for preparing same, pharmaceutical composition and use thereof
IL219872A (en) Quinazoline derivatives, their uses, their preparation, and their medications
GB201014023D0 (en) Process for producing bioconjugates and products thereof
EP2616120A4 (en) ADMINISTRATION APPARATUS, METHOD OF OPERATION THEREFOR, AND METHOD OF ADMINISTRATION
EP2415467A4 (en) METHOD FOR PRODUCING A UBICHINONE POWDER FOR USE IN PREPARATIONS AND PRODUCTS THEREOF
ZA201108148B (en) Triazine-aryl-bis-indoles and process for preparation thereof
HU0900305D0 (en) Peptide derivatives, process for their preparation and their therapeutical use
IL234008A (en) The process of obtaining a modafinil-based pharmacy, the resulting pharmacy and its use
GB201020398D0 (en) Potash product, method and apparatus
PT3539540T (pt) Inibidor de sglt2 1-cloro-4-(beta-d-glucopiranos-1-il)-2-[4-((s)-tetra-hidrofurano-3-iloxi)-benzil]-benzeno em combinação com insulina para utilização num método para redução do risco de hipoglicemia
PL392488A1 (pl) Sposób jednoczesnego wytwarzania 3ß,7α-dihydroksyandrost-5-en-17-onu i 3ß,7ß-dihydroksyandrost-5-en-17-onu